Randomized controlled study on preoperative chemoradiotherapy followed by surgery versus surgery alone for esophageal squamous cell cancer in a single institution

Diseases of the Esophagus

Volumn 19, Issue 6, 2006, Pages 468-472

  Natsugoe, S ^a   Okumura, H ^a   Matsumoto, M ^a   Uchikado, Y ^a   Setoyama, T ^a   Yokomakura, N ^a   Ishigami, S ^a   Owaki, T ^a   Aikou, T ^a  

^a KAGOSHIMA UNIVERSITY   (Japan)

Author keywords

Chemoradiation therapy; Esophageal cancer; Randomized controlled study

Indexed keywords

CISPLATIN; FLUOROURACIL;

ADULT; AGED; ANEMIA; ANOREXIA; ARTICLE; BONE MARROW SUPPRESSION; BONE METASTASIS; CANCER COMBINATION CHEMOTHERAPY; CANCER GRADING; CANCER MORTALITY; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; ESOPHAGUS RESECTION; FOLLOW UP; GASTROINTESTINAL SYMPTOM; HISTOPATHOLOGY; HUMAN; LEUKOPENIA; LYMPH NODE METASTASIS; PREOPERATIVE RADIOTHERAPY; PREOPERATIVE TREATMENT; PRIORITY JOURNAL; RADIATION DOSE; RANDOMIZED CONTROLLED TRIAL; SURVIVAL RATE; SURVIVAL TIME; THROMBOCYTOPENIA; TREATMENT RESPONSE;

CHEMOTHERAPY, ADJUVANT; ESOPHAGEAL NEOPLASMS; ESOPHAGECTOMY; HUMANS; NEOADJUVANT THERAPY; NEOPLASM INVASIVENESS; PROGNOSIS; RADIOTHERAPY DOSAGE; RADIOTHERAPY, ADJUVANT; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 33750431372     PISSN: 11208694     EISSN: 14422050     Source Type: Journal    
DOI: 10.1111/j.1442-2050.2006.00615.x     Document Type: Article

References (34)

1. Baba M, Aikou T, Yoshinaka H et al. Long-term results of subtotal esophagectomy with three-field lymphadenectomy for carcinoma of the thoracic esophagus. Ann Surg 1994; 219: 310-16.
2. Kelsen D P, Ginsberg R, Pajak T F et al. Chemotherapy followed by surgery compared with surgery alone for localized esophageal cancer. N Engl J Med 1998; 339: 1979-84.
3. Bosset J F, Gignoux M, Triboulet J P et al. Chemoradiotherapy followed by surgery compared with surgery alone in squamous-cell cancer of the esophagus. N Engl J Med 1997; 337: 161-7.
4. Stahl M, Stuschke M, Lehmann N et al. Chemoradiation with and without surgery in patients with locally advanced squamous cell carcinoma of the esophagus. J Clin Oncol 2005; 23: 2310-17.
5. Burmeister B H, Smithers B M, Gebski V et al. Surgery alone versus chemoradiotherapy followed by surgery for resectable cancer of the oesophagus: A randomised controlled phase III trial. Lancet Oncol 2005; 6: 659-68.
6. Greer S E, Goodney P P, Sutton J E, Birkmeyer J D. Neoadjuvant chemoradiotherapy for esophageal carcinoma: A meta-analysis. Surgery 2005; 137: 172-7.
7. Natsugoe S, Yoshinaka H, Shimada M et al. Number of lymph node metastases determined by presurgical ultrasound and endoscopic ultrasound is related to prognosis in patients with esophageal carcinoma. Ann Surg 2001; 234: 613-18.
8. Izbicki J R, Hosch S B, Pichlmeier U et al. Prognostic value of immunohistochemically identifiable tumor cells in lymph nodes of patients with completely resected esophageal cancer. N Engl J Med 1997; 337: 1188-94.
9. Natsugoe S, Mueller J, Stein H J, Feith M, Hofler H, Siewert J R. Micrometastasis and tumor cell microinvolvement of lymph nodes from esophageal squamous cell carcinoma: Frequency, associated tumor characteristics, and impact on prognosis. Cancer 1998; 83: 858-66.
10. Matsumoto M, Natsugoe S, Nakashima S et al. Clinical significance of lymph node micrometastasis of pN0 esophageal squamous cell carcinoma. Cancer Lett 2000; 153: 189-97.
11. Natsugoe S, Mueller J, Kijima F et al. Extranodal connective tissue invasion and the expression of desmosomal glycoprotein 1 in squamous cell carcinoma of the oesophagus. Br J Cancer 1997; 75: 892-7.
12. International Union against cancer. Sobin L H, Wittekind C H. TNM-classification of Malignant Tumors, 6th edn. New York: Wiley-Liss 2002.
13. Esophageal Disease Research Society. Guidelines for the Clinical and Pathologic Studies on Carcinoma of the Esophagus, 9th edn. Tokyo: Kanehara 1999.
14. Ando N, Iizuka T, Ide H et al. Surgery plus chemotherapy compared with surgery alone for localized squamous cell carcinoma of the thoracic esophagus: A Japan Clinical Oncology Group Study-JCOG9204. J Clin Oncol 2003; 21: 4592-6.
15. Ancona E, Ruol A, Santi S et al. Only pathologic complete response to neoadjuvant chemotherapy improves significantly the long term survival of patients with resectable esophageal squamous cell carcinoma: Final report of a randomized, controlled trial of preoperative chemotherapy versus surgery alone. Cancer 2001; 91: 2165-74.
16. Baba M, Natsugoe S, Shimada M et al. Prospective evaluation of preoperative chemotherapy in resectable squamous cell carcinoma of the thoracic esophagus. Dis Esophagus 2000; 13: 136-41.
17. Doty J R, Salazar J D, Forastiere A A, Heath E I, Kleinberg L, Heitmiller R F. Postesophagectomy morbidity, mortality, and length of hospital stay after preoperative chemoradiation therapy. Ann Thorac Surg 2002; 74: 227-31.
18. Kelley S T, Coppola D, Karl R C. Neoadjuvant chemoradiotherapy is not associated with a higher complication rate vs. surgery alone in patients undergoing esophagectomy. J Gastrointest Surg 2004; 8: 227-31.
19. Rice D C, Correa A M, Vaporciyan A A et al. Preoperative chemoradiotherapy prior to esophagectomy in elderly patients is not associated with increased morbidity. Ann Thorac Surg 2005; 79: 391-7.
20. Boyle M J, Franceschi D, Robinson D S, Livingstone A S. Neoadjuvant therapy for esophageal cancer: Standard of care or elusive myth? Am Surg 2001; 67: 956-65.
21. Takagi K, Yamamori H, Furukawa K, Miyazaki M, Tashiro T. Perioperative supplementation of EPA reduces immunosuppression induced by postoperative chemoradiation therapy in patients with esophageal cancer. Nutrition 2001; 17: 478-9.
22. Slater M S, Holland J, Faigel D O, Sheppard B C, Deveney C W. Does neoadjuvant chemoradiation downstage esophageal carcinoma? Am J Surg 2001; 181: 440-4.
23. Osaka Y, Takagi Y, Tsuchida A et al. Concurrent preoperative chemoradiotherapy for stage III or IV esophageal squamous carcinoma. Oncol Rep 2004; 12: 1121-6.
24. Yeh A M, Mendenhall W M, Morris C G, Zlotecki R A, Desnoyers R J, Vogel S B. Factors predictive of survival for esophageal carcinoma treated with preoperative radiotherapy with or without chemotherapy followed by surgery. J Surg Oncol 2003; 83: 14-23.
25. Vogel S B, Mendenhall W M, Sombeck M D, Marsh R, Woodward E R. Downstaging of esophageal cancer after preoperative radiation and chemotherapy. Ann Surg 1995; 221: 685-93.
26. Liao Z, Zhang Z, Jin J et al. Esophagectomy after concurrent chemoradiotherapy improves locoregional control in clinical stage II or III esophageal cancer patients. Int J Radiat Oncol Biol Phys 2004; 60: 1484-93.
27. Lee J L, Park S I, Kim S B et al. A single institutional phase III trial of preoperative chemotherapy with hyperfractionation radiotherapy plus surgery versus surgery alone for resectable esophageal squamous cell carcinoma. Ann Oncol 2004; 15: 947-54.
28. Malthaner R A, Wong R K, Rumble R B, Zuraw L. Neoadjuvant or adjuvant therapy for resectable esophageal cancer: A systematic review and meta-analysis. BMC Med 2004; 2: 35.
29. Urba S G, Orringer M B, Turrisi A, Iannettoni M, Forastiere A, Strawderman M. Randomized trial of preoperative chemoradiation versus surgery alone in patients with locoregional esophageal carcinoma. J Clin Oncol 2001; 19: 305-13.
30. Frechette E, Buck D A, Kaplan B J et al. Esophageal cancer: Outcomes of surgery, neoadjuvant chemotherapy, and three-dimension conformal radiotherapy. J Surg Oncol 2004; 87: 68-74.
31. Okumura H, Natsugoe S, Matsumoto M et al. The predictive value of p53, 53R2, and p21 for the effect of chemoradiation therapy on oesophageal squamous cell carcinoma. Br J Cancer 2005; 92: 284-9.
32. Takatori H, Natsugoe S, Okumura H et al. Predictive value of COX-2 for the effect of chemoradiotherapy on esophageal squamous cell carcinoma. Oncol Rep 2005; 13: 697-701.
33. Rich T A, Shepard R. COX-2 inhibitors as radiation sensitizers for upper GI tract cancers: Esophagus, stomach, and pancreas. Am J Clin Oncol 2003; 26: S110-13.
34. Kishi K, Doki Y, Miyata H, Yano M, Yasuda T, Monden M. Prediction of the response to chemoradiation and prognosis in oesophageal squamous cancer. Br J Surg 2002; 89: 597-603.